Timeline

Laurie Pinaud

Clinical Research Assistant

22 Dec 2023

course

Viral Outbreaks and Pandemics, A One Health Approach MOOC

01 Jul 2023

publication

Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France.

01 Jun 2023

publication

Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.

01 Sep 2022

publication

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.

17 Mar 2022

course

Vaccinology MOOC

16 Nov 2021

publication

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.

05 May 2021

project

Longitudinal follow-up of a population cohort in a French city with high SARS-CoV-2 circulation in early 2020 : the COVID-Oise cohort

06 Nov 2020

news

Suivi de la persistance de la réponse immunitaire contre le SARS-CoV-2 au sein de la cohorte de Crépy-en-Valois (COVID-Oise)

01 Apr 2018

publication

Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.

13 Feb 2018

publication

Glycan-Glycan Interaction Determines Shigella Tropism toward Human T Lymphocytes.

12 Sep 2017

publication

Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes.

01 Jan 2017

publication

Identification of novel substrates of Shigella T3SA through analysis of its virulence plasmid-encoded secretome.

11 May 2015

team

Epidemiology of Emerging Diseases

02 Jun 2014

publication

B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection.

16 Nov 2012

publication

Salmonella inhibits retrograde trafficking of mannose-6-phosphate receptors and lysosome function.

01 Apr 2012

publication

EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.

03 Jan 1975

publication

A little guide for advanced search:

Timeline

Viral Outbreaks and Pandemics, A One Health Approach MOOC

Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France.

Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.

Vaccinology MOOC

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.

Longitudinal follow-up of a population cohort in a French city with high SARS-CoV-2 circulation in early 2020 : the COVID-Oise cohort

Suivi de la persistance de la réponse immunitaire contre le SARS-CoV-2 au sein de la cohorte de Crépy-en-Valois (COVID-Oise)

Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.

Glycan-Glycan Interaction Determines Shigella Tropism toward Human T Lymphocytes.

Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes.

Identification of novel substrates of Shigella T3SA through analysis of its virulence plasmid-encoded secretome.

Epidemiology of Emerging Diseases

B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection.

Salmonella inhibits retrograde trafficking of mannose-6-phosphate receptors and lysosome function.

EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.

Increased axoplasmic flow associated with pargyline under conditions which induce a myopathy.